Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 6Rectal Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Colonic Neoplasms 5Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Follicular 4Immunoblastic Lymphadenopathy 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Sezary Syndrome 3Pancreatic Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Mantle-Cell 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Esophageal Neoplasms 3Burkitt Lymphoma 3Adenocarcinoma Of Esophagus 3Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Platinum 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1ficlatuzumab 1durvalumab 1dehydroftorafur 1adavosertib 1X-Rays 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Phototherapy 1Photochemotherapy 1Paclitaxel 1Methods 1Metformin 1Immunohistochemistry 1Immunoglobulin G 1Gemcitabine 1Gefitinib 1Fluorouracil 1Educational Status 1Docetaxel 1Disulfides 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoid Interstitial Pneumonia × Immunohistochemistry × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡